GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zimmer Biomet Holdings Inc (XSWX:ZBH) » Definitions » Other Net Income (Loss)

Zimmer Biomet Holdings (XSWX:ZBH) Other Net Income (Loss) : CHF0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2003. Start your Free Trial

What is Zimmer Biomet Holdings Other Net Income (Loss)?

Zimmer Biomet Holdings's Other Net Income (Loss) for the three months ended in Dec. 2023 was CHF-0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF0 Mil.

Zimmer Biomet Holdings's quarterly Other Net Income (Loss) increased from Jun. 2023 (CHF-0 Mil) to Sep. 2023 (CHF0 Mil) but then declined from Sep. 2023 (CHF0 Mil) to Dec. 2023 (CHF-0 Mil).

Zimmer Biomet Holdings's annual Other Net Income (Loss) declined from Dec. 2021 (CHF-40 Mil) to Dec. 2022 (CHF-55 Mil) but then increased from Dec. 2022 (CHF-55 Mil) to Dec. 2023 (CHF0 Mil).


Zimmer Biomet Holdings Other Net Income (Loss) Historical Data

The historical data trend for Zimmer Biomet Holdings's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zimmer Biomet Holdings Other Net Income (Loss) Chart

Zimmer Biomet Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -113.89 -39.97 -54.78 -

Zimmer Biomet Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -0.09 0.09 -

Zimmer Biomet Holdings Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zimmer Biomet Holdings Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Zimmer Biomet Holdings's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Zimmer Biomet Holdings (XSWX:ZBH) Business Description

Traded in Other Exchanges
Address
345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.